Added to YB: 2020-05-28
Pitch date: 2020-05-28
KALA [bullish]
KALA BIO, Inc.
-99.89%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases.
Market Cap
$46.2M
Pitch Price
$617.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.12
P/E
-1.07
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
KALA PHARMECUTICAL INC KALA
A summary for this pitch has not been created yet.
Read full article (0 min)